What is ICON PLC (ICLR)?
ICON PLC is a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company offers a range of clinical research services including trial design, data management, and regulatory consulting. Its operations encompass phases I through IV of clinical trials, supporting drug development from early-stage research to post-market surveillance. ICON PLC utilizes technology and analytics to enhance trial efficiency and data quality. The company serves clients worldwide, including major pharmaceutical firms and emerging biotechs. Its services aim to facilitate the development and approval of new therapies by managing complex clinical programs. ICON PLC operates in a sector driven by innovation, regulatory requirements, and the need for cost-effective research solutions.
ICON PLC Stock Price Today: Live Overview
The price today is shaped by live market trading, with BeOne Medicines Ltd priced at $102.22. It has seen price changes between $98.49 and $101.3 today, with a daily change percentage of -0.0598%.
FAQ: ICON PLC (ICLR)
What is the current price of ICLR stock?
ICON PLC's latest share price is $102.22.
Does ICLR pay dividends?
ICON PLC pays dividends via cash distributions (if applicable).
Does ICLR have a formal corporate presence or regional headquarters in the UAE?
ICON PLC has an official presence in the UAE through a regional office located in Dubai Internet City.
What is ICLR best known for?
The company is most famous for providing clinical research and development services globally.
What assets are typically shown together with ICLR?
Commonly shown alongside ICLR: Gladstone Commercial, Alvotech SA, Toast, Inc.
Latest shares articles



